Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II axitinib study in advanced angiosarcoma and other soft tissue sarcomas
ISRCTN60791336Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Aug 2010
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of axitinib in angiosarcoma, soft tissue sarcoma (STS), synovial sarcoma (SS) and 2 more, sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: 12-week progression-free rate. Started Aug 2010; status: completed.
02
Drugs
axitinib
03
Conditions
angiosarcomasoft tissue sarcoma (STS)synovial sarcoma (SS)leiomyosarcoma (LMS)Kaposi sarcoma (KS)
Beyond the preview
Go deeper on ISRCTN60791336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN60791336.